W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

Summary of information indicated by applicants to be kept confidential in selected areas of the documentation published by AOTMiT (applicant’s analyses, verification analyses, positions of the Transparency Council, recommendations of the President) in the evaluation of reimbursement applications for the year 2021 and Q1 2022.

more...

Opinion of the Transparency Council – tacrolimus

more...

. Opinion of the Transparency Council – chlorambucil

more...

Opinion of the Transparency Council – sulfamethoxazole + trimethoprim

more...

Opinion of the Transparency Council – amoxicillin + clavulanic acid

more...

Opinion of the Transparency Council – amoxicillin

more...

Opinion of the Transparency Council – bisoprolol

more...

Opinion of the Transparency Council – spironolactone

more...

Resolution of the Transparency Council on the effective cost of treatment

more...

Resolution of the Transparency Council on the compilation of valuable interventions in the field of public health

more...

Resolution of the Transparency Council on unpublished clinical efficacy and safety data

more...

Opinion of the Transparency Council – health policy programme of the Podlaskie Voivodeship in the scope of prevention and early detection of colorectal cancer

more...

Opinion of the Transparency Council – health policy programme of the Municipality of Kwidzyn in the scope of the pre-treatment first aid for schoolchildren

more...

Position of the Transparency Council – Kerendia (finerenone)

more...

The Meeting of the Transparency Council No. 38/2022 of 26.09.2022

more...

Opinion of the Transparency Council – sirolimus

more...

Opinion of the Transparency Council – mycophenolate mofetil

more...

Position of the Transparency Council – Impavido (miltefosine)

more...

Position of the Transparency Council – Vivitrol (extended-release naltrexone)

more...

Position of the Transparency Council – Bimzelx (bimekizumab)

more...

Position of the Transparency Council – Ponvory (ponesimod)

more...

Position of the Transparency Council – corneal cross-linking surgery

more...

The Meeting of the Transparency Council No. 37/2022 of 19.09.2022

more...

Opinion of the Transparency Council – the active substance arsenic trioxide

more...